参考文献/References:
[1]中国抗癌协会小儿肿瘤专业委员会,中华医学会小儿外科分会肿瘤专业组.儿童肝母细胞瘤多学科诊疗专家共识(CCCG-HB-2016)[J].中华小儿外科杂志,2017,38(10):733-739.[2]Waters AM,Mathis MS,Beierle EA,et al.A Synopsis of Pediatric Patients With Hepatoblastoma and Wilms Tumor: NSQIP-P 2012-2016[J].Journal of Surgical Research,2019,244:338-342.[3]Li G,Deng L,Huang N,et al.m6A mRNA Methylation Regulates LKB1 to Promote Autophagy of Hepatoblastoma Cells through Upregulated Phosphorylation of AMPK[J].Genes (Basel),2021,12(11):1747.[4]Cui X,Wang Z,Liu L,et al.The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF/c-Met Pathway[J].Frontiers in Cell and Developmental Biology,2019,7:271.[5]Yuan MX,Ji CY,Gao HQ,et al.lncRNA TUG1 regulates angiogenesis via the miR-204-5p/JAK2/STAT3 axis in hepatoblastoma[J].Molecular Medicine Reports,2021,24(2):553.[6]Zhou P,Gao S,Hu B.Exploration of Potential Biomarkers and Immune Landscape for Hepatoblastoma: Evidence from Machine Learning Algorithm[J].Evid Based Complement Alternat Med,2022,2022:2417134.[7]Edgar R,Domrachev M,Lash AE.Gene Expression Omnibus: NCBI gene expression and hybridization array data repository[J].Nucleic Acids Research,2002,30(1):207-210.[8]Masami K,Eiso H,Kasumi K,et al.Gene expression profiling in hepatoblastoma cases of the Japanese Study Group for Pediatric Liver Tumors-2 (JPLT-2) trial[J].European Journal of Molecular Cancer,2019.[9]Carrillo-Reixach J,Torrens L,Simon-Coma M,et al.Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications[J].Journal of Hepatology,2020,73(2):328-341.[10]Sumazin P,Chen Y,Trevi?觡o LR,et al.Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups[J].Hepatology,2017,65(1):104-121.[11]Huang DW,Sherman BT,Tan Q,et al.The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists[J].Genome Biology,2007,8(9):R183.[12]Franceschini A,Szklarczyk D,Frankild S,et al.STRING v9.1: protein-protein interaction networks, with increased coverage and integration[J].Nucleic Acids Research,2012,41:D808-D815.[13]Smoot ME,Ono K,Ruscheinski J,et al.Cytoscape 2.8: new features for data integration and network visualization[J].Bioinformatics,2010,27(3):431-432.[14]Bandettini WP,Kellman P,Mancini C,et al.MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study[J].Journal of Cardiovascular Magnetic Resonance,2012,14(1):83.[15]Maere S,Heymans K,Kuiper M.BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks[J].Bioinformatics,2005,21(16):3448-3449.[16]Kent WJ,Sugnet CW,Furey TS,et al.The human genome browser at UCSC[J].Genome Res,2002,12(6):996-1006.[17]Cerami E,Gao J,Dogrusoz U,et al.The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data[J].Cancer Discovery,2012,2(5):401-404.[18]Hager J,Sergi CM.Hepatoblastoma[M].Brisbane(AU):Exon Publications,2021.[19]Lupo MG,Ferri N.Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects[J].J Cardiovasc Dev Dis,2018,5(3):39.[20]Jiang S,Qiu GH,Zhu N,et al.ANGPTL3: a novel biomarker and promising therapeutic target[J].J Drug Target,2019,27(8):876-884.[21]El-Shal AS,Zidan HE,Rashad NM,et al.Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma[J].Cytokine,2017,96:75-86.[22]Liu X,Quan J,Shen Z,et al.Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer[J].Cancer Cell Int,2022,22(1):205.[23]Janssen AM,van Duijn W,Kubben FJ,et al.Prognostic significance of metallothionein in human gastrointestinal cancer[J].Clin Cancer Res,2002,8(6):1889-1896.[24]Tsangaris GT,Vamvoukakis J,Politis I,et al.Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia[J].Anticancer Res,2000,20(6B):4407-4411.[25]Tekur S,Ho SM.Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines[J].Mol Carcinog,2002,33(1):44-55.[26]Li H,Lu YF,Chen H,et al.Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma[J].Chronobiol Int,2017,34(2):192-202.[27]Zhao Z,Zhang G,Li W.MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells[J].Cell Biochem Biophys,2020,78(4):475-482.[28]Jeyaraj R,Kelly D.Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis[J].Cells,2022,11(16):2570.[29]Pine SR,Mechanic LE,Ambs S,et al.Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene[J].J Natl Cancer Inst,2007,99(18):1401-1409.[30]Blum WF,Alherbish A,Alsagheir A,et al.The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders[J].Endocr Connect,2018,7(6):R212-R222.[31]Vaezi MA,Eghtedari AR,Safizadeh B,et al.Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors[J].Front Oncol,2022,12:1096438.[32]Anisimov VN,Bartke A.The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer[J].Crit Rev Oncol Hematol,2013,87(3):201-223.[33]Abril-Fornaguera J,Torrens L,Andreu-Oller C,et al.Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma[J].Mol Cancer Ther,2023,22(4):485-498.[34]Raedler H,Yang M,Lalli PN,et al.Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation[J].Am J Transplant,2009,9(8):1784-1795.[35]Seol HS,Lee SE,Song JS,et al.Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1[J].Cancer Lett,2016,372(1):24-35.[36]Varsano S,Rashkovsky L,Shapiro H,et al.Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance[J].Clin Exp Immunol,1998,113(2):173-182.[37]Lyon RC,Johnston SM,Panopoulos A,et al.Enzymes involved in the metabolism of gamma-hydroxybutyrate in SH-SY5Y cells:identification of an iron-dependent alcohol dehydrogenase ADHFe1[J].Chem Biol Interact,2009,178(1-3):283-287.[38]Shabtai Y,Shukrun N,Fainsod A.ADHFe1: a novel enzyme involved in retinoic acid-dependent Hox activation[J].Int J Dev Biol,2017,61(3-4-5):303-310.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(11):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]刘 坤,陈德春.基于生信学方法分析GSDM基因家族在膀胱癌的表达及临床意义[J].医学信息,2022,35(10):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
LIU Kun,CHEN De-chun.Expression and Clinical Significance of GSDM Gene Family in Bladder Cancer Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(11):14.[doi:10.3969/j.issn.1006-1959.2022.10.003]
[3]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Journal of Medical Information,2022,35(11):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[4]余世纪,谢勇丽,苏晓清.血清VDBP、IL-8、sTWEAK与尿VDBP早期诊断糖尿病肾病的价值[J].医学信息,2019,32(09):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
YU Shi-ji,XIE Yong-li,SU Xiao-qing.The Value of Serum VDBP,IL-8,sTWEAK and Urine VDBP in Early Diagnosis of Diabetic Nephropathy[J].Journal of Medical Information,2019,32(11):38.[doi:10.3969/j.issn.1006-1959.2019.09.013]
[5]王清华,易守芳,余明芳.肾移植术后药源性肾损伤生物标志物的研究[J].医学信息,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
WANG Qing-hua,YI Shou-fang,YU Ming-fang.Study on Biomarkers of Drug-induced Renal Injury after Renal Transplantation[J].Journal of Medical Information,2019,32(11):44.[doi:10.3969/j.issn.1006-1959.2019.10.016]
[6]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Journal of Medical Information,2019,32(11):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[7]孟 华,苏馨雅,陆雯雯,等.CHA2DS2-VASc评分联合生物标志物对非瓣膜性心房颤动并发脑卒中诊断价值的系统综述[J].医学信息,2023,36(19):179.[doi:10.3969/j.issn.1006-1959.2023.19.041]
MENG Hua,SU Xin-ya,LU Wen-wen,et al.A Systematic Review of the Diagnostic Value of CHA2DS2-VASc Score Combined with Biomarkers for Non-valvular Atrial Fibrillation Complicated by Stroke[J].Journal of Medical Information,2023,36(11):179.[doi:10.3969/j.issn.1006-1959.2023.19.041]
[8]施晓萍,韦 拔,蒋永江,等.新生儿败血症诊断中的生物标志物研究现状[J].医学信息,2020,33(06):35.[doi:10.3969/j.issn.1006-1959.2020.06.011]
SHI Xiao-ping,WEI Ba,JIANG Yong-jiang,et al.Research Status of Biomarkers in the Diagnosis of Neonatal Sepsis[J].Journal of Medical Information,2020,33(11):35.[doi:10.3969/j.issn.1006-1959.2020.06.011]
[9]胡 静,钟晓波,朱士胜,等.颞下颌关节骨关节病关节液的定量蛋白质组学研究[J].医学信息,2020,33(10):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]
HU Jing,ZHONG Xiao-bo,ZHU Shi-sheng,et al.Quantitative Proteomics Study on Joint Fluid of Temporomandibular Joint Osteoarthropathy[J].Journal of Medical Information,2020,33(11):65.[doi:10.3969/j.issn.1006-1959.2020.10.019]
[10]陈朴阳,刘 涛,范凯健.类风湿性关节炎的生物标志物及其测定[J].医学信息,2020,33(15):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]
CHEN Pu-yang,LIU Tao,FAN Kai-jian.Biomarkers of Rheumatoid Arthritis and Their Determination[J].Journal of Medical Information,2020,33(11):37.[doi:10.3969/j.issn.1006-1959.2020.15.013]